Activity of Afatinib in Heavily Pretreated Patients With ERBB2 Mutation–Positive Advanced NSCLC: Findings From a Global Named Patient Use Program
Autor: | Peters, Solange, Curioni-Fontecedro, Alessandra, Nechushtan, Hovav, Shih, Jin-Yuan, Liao, Wei-Yu, Gautschi, Oliver, Spataro, Vito, Unk, Mojca, Yang, James Chih-Hsin, Lorence, Robert M., Carrière, Philippe, Cseh, Agnieszka, Chang, Gee-Chen |
---|---|
Zdroj: | In Journal of Thoracic Oncology December 2018 13(12):1897-1905 |
Databáze: | ScienceDirect |
Externí odkaz: |